NASDAQ · SCRM
Screaming Eagle Acquisition Corp.
$10.18-$1.03 (-9.19%)
Screaming Eagle Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 20.72% below the high.
Loading market information…
NASDAQ · TMTC · USD
Stock price
Quote as of Nov 21, 2024, 09:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
TMT Acquisition Corp currently has no major business operations. Its core mission is to achieve a business combination, which might take the form of a merger, stock exchange, asset purchase, share acquisition, recapitalization, or reorganization, with one or more companies. The firm plans to concentrate its search for prospective target businesses primarily in the Asian market. TMT Acquisition Corp was founded in 2021 and maintains its headquarters in New York City.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:44 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$10.18-$1.03 (-9.19%)
Screaming Eagle Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 20.72% below the high.
$0.73-$0.09 (-11.32%)
Estrella Immunopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.87% below the high.
$6.11-$0.97 (-13.71%)
Goldenbridge Acquisition Limited’s quoted price sits in the lower half of its reported 52-week range, 46.87% below the high.
$2.93-$4.38 (-59.92%)
EF Hutton Acquisition Corporation I Common Stock’s quoted price sits in the lower half of its reported 52-week range, 82.76% below the high.
$6.56-$0.64 (-8.89%)
Global Star Acquisition, Inc. Class A Common Stock’s quoted price sits in the lower half of its reported 52-week range, 68.6% below the high.
$3.66-$7.03 (-65.76%)
Bukit Jalil Global Acquisition 1 Ltd’s quoted price sits in the lower half of its reported 52-week range, 69.95% below the high.
$3.82-$6.58 (-63.27%)
Alset Capital Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 74.6% below the high.
$5.18+$0.47 (+9.98%)
Mobiv Acquisition Corp’s quoted price sits in the lower half of its reported 52-week range, 55.91% below the high.
